SAN FRANCISCO, March 10- A U.S. appeals court ruling that significantly boosted gay rights will stand, as a pharmaceutical company involved in the case said on Monday that it would not appeal.» Read More
Soliris, the company's sole product on the market, is approved in the United States, the European Union and Japan for the two conditions. The drugmaker raised its full-year adjusted earnings forecast to $4.37- $4.47 per share from its previous estimate of $3.70- $3.80.
March 10- Alexion Pharmaceuticals Inc revised its profit and sales outlook for the year after the French government agreed to raise reimbursement payments for the company's lead drug, Soliris. The drugmaker raised its full-year adjusted earnings forecast to $4.37- $4.47 per share from its previous estimate of $3.70- $3.80 per share.
LONDON, March 10- GlaxoSmithKline said on Monday it had paid 64 billion rupees to increase its stake in its Indian pharmaceuticals unit to 75 percent, as it banks on rising demand for medicines in emerging markets. Britain's biggest drugmaker first announced plans to lift the holding in GlaxoSmithKline Pharmaceuticals from 50.7 percent in December.
MUMBAI, March 8- Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to poor quality, has recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected.
March 7- Indian drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, U.S. regulators said. Ranbaxy could not be reached for comment outside of India's business hours.
NEW YORK, March 7- InterMune Inc, a drugmaker that specializes in treating fatal scarring of the lungs, is attracting takeover interest from several pharmaceutical companies, according to people familiar with the matter. InterMune had considered selling itself about three years ago and held discussions with potential buyers.
HELENA, Mont.-- Subsidiaries of Johnson& Johnson have agreed to pay $5.9 million to settle a lawsuit with Montana over how an anti-psychotic drug was marketed, state Attorney General Tim Fox said Thursday.
NEW YORK-- Pfizer said Thursday it is recalling some lots of its antidepressant Effexor XR because a single capsule of a different medication was found in one bottle of the drug. Pfizer is recalling two production lots of Effexor XR capsules and one lot of generic Effexor, or venlafaxine, sold by its Greenstone LLC subsidiary.
March 6- Pfizer Inc said on Thursday it was recalling two lots of its Effexor XR antidepressant and another lot of its generic version of the drug after a pharmacist reported finding one capsule of a different medicine in a bottle of Effexor.
Calling it a serious threat, the CDC says American hospitals are overprescribing antibiotics, leaving patients vulnerable to superbugs.
MUMBAI, March 6- Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.
Pfizer is in clinical trials to create an over-the-counter version of cholesterol drug, Lipitor. Barbara Ryan, FTI Consulting, discusses challenges the pharmaceutical will face.
*Reinhardt at Novartis overhauling structure, culture. ZURICH, March 3- When outgoing Lufthansa chief executive Christoph Franz takes over as chairman of Swiss drugmaker Roche on Tuesday, it could be the start of a new era of less-frosty relations with arch-rival Novartis.
The Supreme Court will hear an appeal filed by Omnicare in a securities case filed by investors.
Here's what you need to know about this month's open enrollment countdown.
WASHINGTON, Feb 28- Generic drugmakers are furiously campaigning against a proposed U.S. rule that would require them to change the prescribing information on their products if they receive new safety information, which they say would open them to product liability lawsuits.
WASHINGTON _ The Commerce Department releases personal income and spending for January, 8:30 a.m. Eastern; Institute for Supply Management releases its manufacturing index for February, 10 a.m.; Commerce Department releases construction spending for January, 10 a.m.; House Energy and Commerce subcommittee hearing on proposed changes to generic drug labeling.
WASHINGTON _ Commerce Department releases personal income and spending for January, 8:30 a.m. Eastern; Institute for Supply Management releases its manufacturing index for February, 10 a.m.; Commerce Department releases construction spending for January, 10 a.m.; House Energy and Commerce subcommittee hearing on proposed changes to generic drug labeling.
LONDON, Feb 28- Gains at major German drugmaker Bayer helped to prop up European equities on Friday, although weak earnings in Spain hit the Madrid market. Spanish builders FCC and Sacyr fell 7.2 percent and 3.1 percent respectively after each reported losses for 2013..
Medivation Inc. tumbled in premarket trading Friday, a day after the drugmaker forecast 2014 revenue from its prostate cancer treatment Xtandi that fell short of analyst expectations. Medivation also is studying the drug as a possible treatment for patients before chemotherapy, a broader use that would boost sales.